These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 4308440)

  • 1. [Resistance of tubercle bacilli to cycloserine, viomycin and ethionamide in patients suffering from pulmonary tuberculosis].
    Srednicka-Zajac D; Mysakowska H; Szarewicz-Adamczyk W; Litwin B
    Ann Univ Mariae Curie Sklodowska Med; 1967; 22():71-8. PubMed ID: 4308440
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of pulmonary tuberculosis with reserve drugs in the light of our personal observations].
    Kochnowski G
    Wiad Lek; 1970 Jan; 23(1):9-13. PubMed ID: 4312765
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evolution of antibiograms of bacilli persisting under treatment in the sanatorium].
    Marion L
    Rev Tuberc Pneumol (Paris); 1967; 31(6):785-808. PubMed ID: 4317451
    [No Abstract]   [Full Text] [Related]  

  • 4. Cycloserine plus ethionamide plus pyrazinamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
    Ramakrishnan CV; Parthasarathy R; Sambamoorthy S; Somasundaram PR; Subbammal S
    Indian J Med Res; 1976 Jan; 64(1):76-82. PubMed ID: 818010
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of chronic destructive forms of pulmonary tuberculosis with drugs of the second series in different combinations].
    Mamolat AS; Bialik IB
    Probl Tuberk; 1969; 47(6):23-8. PubMed ID: 4311969
    [No Abstract]   [Full Text] [Related]  

  • 6. [Kanamycin and florimycin in the clinical course of pulmonary tuberculosis].
    Bialik IB
    Antibiotiki; 1971 Feb; 16(2):184-8. PubMed ID: 4326728
    [No Abstract]   [Full Text] [Related]  

  • 7. [Primary drug resistance of Mycobacterium tuberculosis to 2d line preparations].
    Fedotova ZN; Gur'ian IE; Kochetov BI
    Probl Tuberk; 1972; 50(11):21-4. PubMed ID: 4630564
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug therapy of resistant cases of pulmonary tuberculosis in Indian patients.
    Mital OP; Agarwala MC; Singh SK
    Indian J Chest Dis; 1967 Oct; 9(4):196-206. PubMed ID: 4323543
    [No Abstract]   [Full Text] [Related]  

  • 9. [The proportion method of determination of the resistance of tubercle bacilli to ethionamide, cycloserine and viomycin].
    Zduńczyk-Pawelek H
    Gruzlica; 1966 Mar; 34(3):255-63. PubMed ID: 4287801
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pulmonary tuberculosis resistant to streptomycin and isoniazid and treated wtih a combination of ethionamide, pyrazinamide, and cycloserine (200 cases)].
    Bartal M; Nejjar A; Laraki A
    Tunis Med; 1973 Jul; 51(4):237-43. PubMed ID: 4209977
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests].
    Tsukamura M
    Kekkaku; 1971 Oct; 46(10):405-8. PubMed ID: 4112456
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs.
    Oka S; Motomiya M; Kato S; Sato H; Fujimoto M
    Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):91-3. PubMed ID: 4968094
    [No Abstract]   [Full Text] [Related]  

  • 13. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
    Matsumoto M; Izumi K; Kamima H; Hirose H; Saito M
    Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
    [No Abstract]   [Full Text] [Related]  

  • 14. The results of treatment in patients with cultures resistant to streptomycin, isoniazid and PAS: a five-year follow-up.
    Tousek J; Jancik E; Zelenka M; Jancikova-Máková M
    Tubercle; 1967 Mar; 48(1):27-31. PubMed ID: 4291925
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bacteriostatic activity of preparations of the 2d series and criteria of the resistance to them].
    Mkrtchian SV; Afanas'eva IuP
    Probl Tuberk; 1967; 45(8):70-5. PubMed ID: 4303640
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
    Zierski M
    Bull Int Union Tuberc; 1968 Dec; 41():194-200. PubMed ID: 4303863
    [No Abstract]   [Full Text] [Related]  

  • 17. [Secondary antitubercular drugs in the treatment of childhood tuberculosis].
    de Lacerda A
    Rev Port Pediatr Pueric; 1967 May; 30(5):149-56. PubMed ID: 4303078
    [No Abstract]   [Full Text] [Related]  

  • 18. Newer and second-line drugs in the treatment of drug-resistant tuberculosis in children.
    Steiner M
    Med Clin North Am; 1967 Sep; 51(5):1153-67. PubMed ID: 4297572
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment with new antitubercular agents].
    Gartmann J
    Dtsch Med Wochenschr; 1968 Nov; 93(47):2281-2. PubMed ID: 4301079
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital].
    Sirota DS; Man'kovetskiĭ EF; Koĭfman SG; Vatsyk MZ
    Probl Tuberk; 1974; (10):17-9. PubMed ID: 4370967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.